Mood Ingredients Market - 2026-2033
Description
MOOD INGREDIENTS MARKET OVERVIEW
Global Mood Ingredients Market reached US$ 249.96 million in 2025 and is expected to reach US$ 428.83 million by 2033, growing with a CAGR of 6.98% during the forecast period 2026-2033. The global mood ingredients market is expanding due to rising stress, anxiety, and lifestyle-related mental health concerns, which are driving demand for natural, functional, and preventive solutions. Brands and ingredient suppliers are responding by developing clinically backed adaptogens, amino acids, psychobiotics, and plant-based extracts designed to support mood, cognitive performance, and emotional balance.
For example, in 2025, many companies have launched products and expanded into the wellness market, and functional beverage innovators such as Better Food Co. introduced adaptogen‑enhanced mushroom cacao beverages in 2025 to deliver stress‑support benefits in convenient formats. The developments demonstrate how ingredient innovation and cross‑category product launches are accelerating the integration of mood‑support ingredients across supplements, beverages, and functional foods.
Source : DataM Intelligence
MOOD INGREDIENTS INDUSTRY TRENDS AND STRATEGIC INSIGHTS
• Asia-Pacific is the fastest-growing region in the mood ingredients market, capturing a share of 25.01% in 2025.
• By ingredient type, the botanical extracts are projected to be the largest market, holding a significant share of about 32.4% in 2025.
GLOBAL MOOD INGREDIENTS MARKET SIZE AND FUTURE OUTLOOK
• 2025 Market Size: US$ 249.96 Million
• 2033 Projected Market Size: US$ 428.83 Million
• CAGR (2026-2033): 6.98%
• Largest Market: North America
• Fastest Market: Asia-Pacific Source : DataM Intelligence
MARKET SCOPE
Metrics Details
By Ingredient Type Botanical Extracts, Proteins and Amino Acids, Vitamins and Minerals, Probiotics and Postbiotics, Omega Fatty Acids, Others
By Application Dietary Supplements, Functional Foods and Beverages, Personal Care and Beauty Products, Pet Nutrition and Supplements, Pharmaceuticals, Others
By Health Benefit Stress Reduction, Mood Elevation, Anxiety Relief, Sleep Support, Cognitive Balance and Focus, Hormonal Mood Regulation, Others
By Source Plant-Based, Animal-Based, Synthetic or Bioidentical, Fermented or Biotechnological
By Distribution Channel B2B Ingredient Suppliers, B2C
By Region North America, South America, Europe, Asia-Pacific, Middle East, and Africa
Report Insights Covered Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth
MARKET DYNAMICS
RISING PREVALENCE OF STRESS AND ANXIETY DISORDERS
The increasing prevalence of stress and anxiety is a key driver for the global mood ingredients market, as consumers seek natural and preventive solutions to support emotional well-being. According to the APA Stress in America 2025 survey, 62% of U.S. adults cite societal division as a major stressor, while over half report feeling isolated or emotionally disconnected. Additionally, 42.5 million adults in the U.S. are living with anxiety disorders in 2025, with 43% indicating higher anxiety levels compared to the previous year, reflecting a widespread need for functional ingredients like adaptogens, psychobiotics, and botanical extracts to promote mood and cognitive resilience.
The impact extends to younger populations as well. In 2023–24, there were 204,526 new referrals for patients aged 17 or under where anxiety was the primary cause, more than double the pre-pandemic rate. Rising urbanization, long working hours, and digital fatigue are further amplifying stress levels globally, driving the adoption of supplements, functional foods, and beverages containing clinically backed mood-supporting ingredients. The increasing burden of mental health challenges across all age groups is expected to sustain strong growth in the mood ingredients market.
REGULATORY COMPLEXITY AND MARKET ADOPTION CHALLENGES
Despite strong demand, the mood ingredients market faces uncertainty due to complex regulatory requirements and variability in ingredient efficacy. Developing and marketing functional ingredients for stress, mood, and cognitive support requires significant investment in clinical trials, standardization, and quality assurance to meet FDA, EFSA, and other regional standards. Smaller ingredient suppliers or startups may struggle to navigate these regulations, causing formulators and brands to be cautious about adopting new or niche ingredients.
Regulatory scrutiny, coupled with consumer skepticism and high pricing of premium botanicals, probiotics and postbiotics, and amino acids, limits broader adoption. Stability and formulation challenges, such as maintaining probiotic viability or preventing degradation of plant extracts in functional foods and beverages, further restrict scale-up. Supply chain variability, interactions with medications, and fragmented awareness across emerging markets also increase risk, making companies prioritize well-established ingredients with proven efficacy and reliable sourcing over newer alternatives.
SEGMENTATION ANALYSIS
The global mood ingredients market is segmented based on ingredient type, application, health benefit, source, distribution channel, and region.
Source : DataM Intelligence
INCREASING ADOPTION OF PLANT-BASED MOOD ENHANCERS STRENGTHENS BOTANICAL EXTRACTS SEGMENT GROWTH
The botanical extracts segment holds a dominant position in the global mood ingredients market, accounting for an estimated 32.4% share of the ingredient type segment in 2025, driven by strong consumer preference for natural, plant-derived stress-relief solutions. Ingredients such as adaptogens, ashwagandha and rhodiola are widely adopted due to their perceived safety, clean-label positioning, and holistic benefits, including stress reduction, enhanced energy, and emotional balance.
Ongoing product innovation is further reinforcing the segment’s market leadership by improving ingredient efficacy, dosage convenience, and application versatility across functional foods, beverages, and supplements. For instance, in May 2025, Natural Remedies, an India-based global botanical ingredients company, introduced Ashwa.30, a next-generation ashwagandha extract formulated to deliver enhanced energy, endurance, and stress-relief benefits at a low 30 mg daily dose. In March 2025, Nutrition21, a U.S.-based functional ingredient manufacturing company, launched EverZen, a novel plant-based bioactive ingredient standardized to 6-MBOA that has been clinically shown to promote a positive mood and support a healthy stress response at a low 250 mg dose. Such advancements are accelerating adoption among manufacturers and consumers, strengthening botanical extracts' commercial position within the broader mood-support ingredients market.
RAPID EXPANSION OF PROBIOTICS AND POSTBIOTICS ACCELERATES MOOD INGREDIENTS MARKET GROWTH
Probiotics and postbiotics are emerging as the fastest-growing segment of the global mood ingredients market, supported by robust scientific research highlighting the influence of the gut–brain axis on mental health outcomes. Strains such as Lactobacillus and Bifidobacterium are increasingly incorporated into mood-focused formulations for their ability to support stress reduction, anxiety management, and emotional balance. Growing consumer awareness of microbiome health, combined with demand for science-backed, non-stimulant mood solutions, is driving adoption across dietary supplements and functional foods.
In 2025, probiotics and postbiotics account for an estimated 10% share of the overall mood ingredients market, with innovation-led product development reinforcing segment growth. For instance, in September 2025, Seed Health, a U.S.-based microbiome science company specializing in probiotics and therapeutic microbiome solutions, launched its Co-Biotics platform to deliver targeted mood, sleep, and cognitive health benefits through the gut–brain axis. Such clinically driven launches are strengthening the commercial relevance of probiotics and postbiotics, positioning the segment as a key growth catalyst within the evolving mood ingredients market.
GEOGRAPHICAL PENETRATION
Source : DataM Intelligence
RISING MENTAL WELLNESS AWARENESS ACCELERATES MOOD INGREDIENTS ADOPTION IN ASIA-PACIFIC
Asia-Pacific is the fastest-growing region in the global mood ingredients market, accounting for approximately 25.01% of the total market share in 2025. Growth is fueled by rising stress levels associated with rapid urbanization, increasing awareness of mental well-being, and strong cultural acceptance of botanical and traditional wellness solutions. Expanding middle-class populations, rising disposable incomes, and a growing focus on preventive healthcare are further accelerating the adoption of mood-support ingredients across dietary supplements and functional foods.
Regional and global ingredient manufacturers are strengthening their footprint by launching plant-based adaptogens, amino acids, probiotics, and postbiotics tailored to local consumer preferences. For instance, in September 2025, Morinaga Milk Industry Co. Ltd, a Japan-based dairy and functional ingredient company, launched its first mood-support postbiotic ingredient, LAC-Living+ (Lactobacillus helveticus MCC1848), at Vitafoods Asia 2025, designed to support positive mood through the gut–brain axis and expand global access to mood-focused postbiotics. Such innovation-led product introductions are reinforcing Asia-Pacific’s role as a key growth engine shaping the future of the global mood ingredients market.
INDIA MOOD INGREDIENTS MARKET OUTLOOK
India’s rapidly expanding wellness economy, combined with the rising prevalence of stress, anxiety, and lifestyle-related mental health concerns, is driving strong demand for mood-support ingredients. Increasing urbanization, extended working hours, and digital fatigue are encouraging consumers to adopt preventive and natural health solutions. India’s deep-rooted acceptance of Ayurvedic and botanical ingredients such as ashwagandha, brahmi, and tulsi continues to support widespread market adoption.
At the same time, the rapid growth of the nutraceuticals and functional foods sector, supported by expanding e-commerce and D2C supplement brands, is accelerating ingredient uptake. For instance, in May 2025, Natural Remedies, an India-based global botanical ingredients company, introduced Ashwa.30, a next-generation ashwagandha extract designed to deliver enhanced energy, endurance, and stress-relief benefits at a low 30 mg daily dose. Such innovation-driven launches highlight the shift toward clinically backed, standardized botanicals. Collectively, these factors position India as a key growth engine in the Asia-Pacific mood ingredients market.
CHINA MOOD INGREDIENTS MARKET TRENDS
China is emerging as a leading market for mood ingredients in the Asia-Pacific region, driven by high urban stress levels, competitive work environments, and increasing focus on preventive health solutions. Growth is supported by large-scale functional food and beverage production, where mood-support ingredients are being incorporated into ready-to-drink beverages, dairy products, and fortified foods. The country’s advanced processing and formulation capabilities enable bioactives to achieve improved stability, taste, and application versatility, meeting consumer expectations for convenience and efficacy.
For instance, in November 2025, Natural Field Co., Ltd, a China-based high-tech nutrition ingredient company, launched its NF Ashwa, a Ashwagandha Extract series, featuring water-soluble and debittered extracts designed for enhanced taste and adaptability across beverages, functional foods, and dietary supplements. Such innovations demonstrate China’s focus on scalable, consumer-friendly mood-support solutions, reinforcing its position as a major growth driver in the Asia-Pacific mood ingredients market.
GROWING EMPHASIS ON COGNITIVE HEALTH ACCELERATES MOOD INGREDIENTS ADOPTION IN NORTH AMERICA
North America is the dominating region in the global mood ingredients market, holding an estimated 38.10% share in 2025, driven by strong consumer focus on mental well-being and preventive health. Widespread adoption of dietary supplements, functional foods, and beverages, along with a well-established nutraceutical industry, is fueling demand for botanical extracts, amino acids, vitamins, and probiotics and postbiotics. Advanced research infrastructure and emphasis on clinically validated, science-backed formulations support rapid innovation and premium product development.
For instance, in November 2025, Maypro Industries, a U.S.‑based global nutraceutical ingredient supplier, partnered with ClostraBio to launch CLB101, a next‑generation Anaerostipes caccae probiotic strain capable of directly producing butyrate to support gut integrity and microbiome balance, marking a significant step in bringing advanced gut‑brain axis‑related ingredients into the North American supplement market.
U.S. MOOD INGREDIENTS MARKET INSIGHTS
The U.S. remains the largest market for mood ingredients globally, driven by high consumer awareness of mental wellness, preventive health, and functional nutrition. Consumers increasingly demand science-backed, convenient formats such as gummies, beverages, and fortified foods. Strong nutraceutical infrastructure and research capabilities support rapid innovation in botanical extracts, amino acids, probiotics and postbiotics, and mood-supporting botanicals. Clinically validated formulations and premium positioning continue to reinforce market leadership.
For instance, in June 2025, OLLY Vitamins, a U.S.-based wellness brand, launched OLLY Mood + Skin, a science-backed personal care line featuring body washes, scrubs, and serums formulated with mood-enhancing fragrances and clinically supported vitamin complexes to support emotional well-being and skin health. Similarly, in November 2025, Maypro Industries partnered with ClostraBio to launch CLB101, a next-generation probiotic strain supporting gut integrity and the gut–brain axis. Such innovations highlight the focus on consumer-friendly, clinically validated mood solutions, reinforcing its global dominance.
CANADA MOOD INGREDIENTS INDUSTRY GROWTH
Canada is emerging as a strong growth market for mood ingredients, driven by rising interest in cognitive health, natural nootropics, and functional wellness products. Regulatory support for dietary supplements and functional foods, combined with a health-conscious consumer base, is encouraging product development and adoption. Canadian companies are increasingly leveraging biotech and innovative delivery formats to bring new solutions to market. Partnerships and acquisitions are strengthening domestic capabilities while expanding North American reach.
For instance, in August 2025, Doseology Sciences Inc., a Canada-based biotech innovation company, completed the acquisition of the Feed That Brain™ division, expanding its portfolio with a wellness brand focused on cognitive performance and mental health supplements. This move enhances Canada’s contribution to North America’s mood-support ecosystem, demonstrating strategic investment in clinically validated, consumer-ready formulations. The activities reinforce Canada’s growing importance in the regional market.
SUSTAINABILITY ANALYSIS
The global mood ingredients market is increasingly integrating sustainability into ingredient sourcing and production, as companies focus on natural, plant-based, and responsibly sourced compounds to meet consumer demand for environmentally conscious nutrition. Ingredients such as botanical extracts, prebiotics, probiotics, and omega-3s are now being developed with a focus on reducing ecological impact while maintaining functional efficacy. The primary environmental footprint arises from agricultural cultivation, extraction processes, and transportation, where energy, water, and raw material usage contribute to overall carbon emissions.
However, sustainability initiatives are accelerating across the industry. Programs like Nexira’s Carbon‑Neutral Natural Acacia Program use sustainably harvested acacia to produce prebiotic fibers with a minimal carbon footprint, while the Arctic Blue Omega Sustainable Omega‑3 Initiative repurposes by-products from MSC-certified cod oil to reduce environmental impact and provide high-quality omega-3s for brain and mood health. By adopting such eco-friendly sourcing and production strategies, ingredient suppliers are lowering the environmental footprint of mood-support products, while also creating a competitive advantage as consumers increasingly favor clean-label, ethical, and sustainable functional ingredients.
COMPETITIVE LANDSCAPE
Source : DataM Intelligence• The global mood ingredients market is characterized by a competitive landscape that includes both established and regional players.
• Key players include DSM-Firmenich, BASF SE, Archer Daniels Midland Company (ADM), Cargill, Incorporated, Kerry Group plc, Ingredion Incorporated, Tate & Lyle PLC, International Flavors & Fragrances, Inc. (IFF), Ajinomoto Co., Inc., and Lonza Group AG.
KEY DEVELOPMENTS
• In 2025, Givaudan, a Switzerland-based flavor and ingredient manufacturer, launched Zensera, a clinically researched lemon balm extract that supports cognitive performance and stress management at a low 300 mg dose, providing brands with a clean‑label, natural ingredient for incorporation into beverages and nutraceuticals aimed at mood support.
• In 2025, OmniActive Health Technologies, an India-based botanicals and functional ingredient company, expanded the reach of its Sleeproot and Zenroot plant-based extracts for mood, stress, and sleep into key European markets, enabling formulators to include clinically backed botanical solutions in functional foods, beverages, and supplements.
• In 2025, Celsius Holdings, a U.S.-based performance beverage and wellness company, completed the acquisition of Alani Nu, broadening its portfolio with a leading functional beverage and supplement brand and strengthening its position in the mood and wellness segment.
WHY CHOOSE DATAM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
TARGET AUDIENCE 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
Emerging Companies
Global Mood Ingredients Market reached US$ 249.96 million in 2025 and is expected to reach US$ 428.83 million by 2033, growing with a CAGR of 6.98% during the forecast period 2026-2033. The global mood ingredients market is expanding due to rising stress, anxiety, and lifestyle-related mental health concerns, which are driving demand for natural, functional, and preventive solutions. Brands and ingredient suppliers are responding by developing clinically backed adaptogens, amino acids, psychobiotics, and plant-based extracts designed to support mood, cognitive performance, and emotional balance.
For example, in 2025, many companies have launched products and expanded into the wellness market, and functional beverage innovators such as Better Food Co. introduced adaptogen‑enhanced mushroom cacao beverages in 2025 to deliver stress‑support benefits in convenient formats. The developments demonstrate how ingredient innovation and cross‑category product launches are accelerating the integration of mood‑support ingredients across supplements, beverages, and functional foods.
Source : DataM Intelligence
MOOD INGREDIENTS INDUSTRY TRENDS AND STRATEGIC INSIGHTS
• Asia-Pacific is the fastest-growing region in the mood ingredients market, capturing a share of 25.01% in 2025.
• By ingredient type, the botanical extracts are projected to be the largest market, holding a significant share of about 32.4% in 2025.
GLOBAL MOOD INGREDIENTS MARKET SIZE AND FUTURE OUTLOOK
• 2025 Market Size: US$ 249.96 Million
• 2033 Projected Market Size: US$ 428.83 Million
• CAGR (2026-2033): 6.98%
• Largest Market: North America
• Fastest Market: Asia-Pacific Source : DataM Intelligence
MARKET SCOPE
Metrics Details
By Ingredient Type Botanical Extracts, Proteins and Amino Acids, Vitamins and Minerals, Probiotics and Postbiotics, Omega Fatty Acids, Others
By Application Dietary Supplements, Functional Foods and Beverages, Personal Care and Beauty Products, Pet Nutrition and Supplements, Pharmaceuticals, Others
By Health Benefit Stress Reduction, Mood Elevation, Anxiety Relief, Sleep Support, Cognitive Balance and Focus, Hormonal Mood Regulation, Others
By Source Plant-Based, Animal-Based, Synthetic or Bioidentical, Fermented or Biotechnological
By Distribution Channel B2B Ingredient Suppliers, B2C
By Region North America, South America, Europe, Asia-Pacific, Middle East, and Africa
Report Insights Covered Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth
MARKET DYNAMICS
RISING PREVALENCE OF STRESS AND ANXIETY DISORDERS
The increasing prevalence of stress and anxiety is a key driver for the global mood ingredients market, as consumers seek natural and preventive solutions to support emotional well-being. According to the APA Stress in America 2025 survey, 62% of U.S. adults cite societal division as a major stressor, while over half report feeling isolated or emotionally disconnected. Additionally, 42.5 million adults in the U.S. are living with anxiety disorders in 2025, with 43% indicating higher anxiety levels compared to the previous year, reflecting a widespread need for functional ingredients like adaptogens, psychobiotics, and botanical extracts to promote mood and cognitive resilience.
The impact extends to younger populations as well. In 2023–24, there were 204,526 new referrals for patients aged 17 or under where anxiety was the primary cause, more than double the pre-pandemic rate. Rising urbanization, long working hours, and digital fatigue are further amplifying stress levels globally, driving the adoption of supplements, functional foods, and beverages containing clinically backed mood-supporting ingredients. The increasing burden of mental health challenges across all age groups is expected to sustain strong growth in the mood ingredients market.
REGULATORY COMPLEXITY AND MARKET ADOPTION CHALLENGES
Despite strong demand, the mood ingredients market faces uncertainty due to complex regulatory requirements and variability in ingredient efficacy. Developing and marketing functional ingredients for stress, mood, and cognitive support requires significant investment in clinical trials, standardization, and quality assurance to meet FDA, EFSA, and other regional standards. Smaller ingredient suppliers or startups may struggle to navigate these regulations, causing formulators and brands to be cautious about adopting new or niche ingredients.
Regulatory scrutiny, coupled with consumer skepticism and high pricing of premium botanicals, probiotics and postbiotics, and amino acids, limits broader adoption. Stability and formulation challenges, such as maintaining probiotic viability or preventing degradation of plant extracts in functional foods and beverages, further restrict scale-up. Supply chain variability, interactions with medications, and fragmented awareness across emerging markets also increase risk, making companies prioritize well-established ingredients with proven efficacy and reliable sourcing over newer alternatives.
SEGMENTATION ANALYSIS
The global mood ingredients market is segmented based on ingredient type, application, health benefit, source, distribution channel, and region.
Source : DataM Intelligence
INCREASING ADOPTION OF PLANT-BASED MOOD ENHANCERS STRENGTHENS BOTANICAL EXTRACTS SEGMENT GROWTH
The botanical extracts segment holds a dominant position in the global mood ingredients market, accounting for an estimated 32.4% share of the ingredient type segment in 2025, driven by strong consumer preference for natural, plant-derived stress-relief solutions. Ingredients such as adaptogens, ashwagandha and rhodiola are widely adopted due to their perceived safety, clean-label positioning, and holistic benefits, including stress reduction, enhanced energy, and emotional balance.
Ongoing product innovation is further reinforcing the segment’s market leadership by improving ingredient efficacy, dosage convenience, and application versatility across functional foods, beverages, and supplements. For instance, in May 2025, Natural Remedies, an India-based global botanical ingredients company, introduced Ashwa.30, a next-generation ashwagandha extract formulated to deliver enhanced energy, endurance, and stress-relief benefits at a low 30 mg daily dose. In March 2025, Nutrition21, a U.S.-based functional ingredient manufacturing company, launched EverZen, a novel plant-based bioactive ingredient standardized to 6-MBOA that has been clinically shown to promote a positive mood and support a healthy stress response at a low 250 mg dose. Such advancements are accelerating adoption among manufacturers and consumers, strengthening botanical extracts' commercial position within the broader mood-support ingredients market.
RAPID EXPANSION OF PROBIOTICS AND POSTBIOTICS ACCELERATES MOOD INGREDIENTS MARKET GROWTH
Probiotics and postbiotics are emerging as the fastest-growing segment of the global mood ingredients market, supported by robust scientific research highlighting the influence of the gut–brain axis on mental health outcomes. Strains such as Lactobacillus and Bifidobacterium are increasingly incorporated into mood-focused formulations for their ability to support stress reduction, anxiety management, and emotional balance. Growing consumer awareness of microbiome health, combined with demand for science-backed, non-stimulant mood solutions, is driving adoption across dietary supplements and functional foods.
In 2025, probiotics and postbiotics account for an estimated 10% share of the overall mood ingredients market, with innovation-led product development reinforcing segment growth. For instance, in September 2025, Seed Health, a U.S.-based microbiome science company specializing in probiotics and therapeutic microbiome solutions, launched its Co-Biotics platform to deliver targeted mood, sleep, and cognitive health benefits through the gut–brain axis. Such clinically driven launches are strengthening the commercial relevance of probiotics and postbiotics, positioning the segment as a key growth catalyst within the evolving mood ingredients market.
GEOGRAPHICAL PENETRATION
Source : DataM Intelligence
RISING MENTAL WELLNESS AWARENESS ACCELERATES MOOD INGREDIENTS ADOPTION IN ASIA-PACIFIC
Asia-Pacific is the fastest-growing region in the global mood ingredients market, accounting for approximately 25.01% of the total market share in 2025. Growth is fueled by rising stress levels associated with rapid urbanization, increasing awareness of mental well-being, and strong cultural acceptance of botanical and traditional wellness solutions. Expanding middle-class populations, rising disposable incomes, and a growing focus on preventive healthcare are further accelerating the adoption of mood-support ingredients across dietary supplements and functional foods.
Regional and global ingredient manufacturers are strengthening their footprint by launching plant-based adaptogens, amino acids, probiotics, and postbiotics tailored to local consumer preferences. For instance, in September 2025, Morinaga Milk Industry Co. Ltd, a Japan-based dairy and functional ingredient company, launched its first mood-support postbiotic ingredient, LAC-Living+ (Lactobacillus helveticus MCC1848), at Vitafoods Asia 2025, designed to support positive mood through the gut–brain axis and expand global access to mood-focused postbiotics. Such innovation-led product introductions are reinforcing Asia-Pacific’s role as a key growth engine shaping the future of the global mood ingredients market.
INDIA MOOD INGREDIENTS MARKET OUTLOOK
India’s rapidly expanding wellness economy, combined with the rising prevalence of stress, anxiety, and lifestyle-related mental health concerns, is driving strong demand for mood-support ingredients. Increasing urbanization, extended working hours, and digital fatigue are encouraging consumers to adopt preventive and natural health solutions. India’s deep-rooted acceptance of Ayurvedic and botanical ingredients such as ashwagandha, brahmi, and tulsi continues to support widespread market adoption.
At the same time, the rapid growth of the nutraceuticals and functional foods sector, supported by expanding e-commerce and D2C supplement brands, is accelerating ingredient uptake. For instance, in May 2025, Natural Remedies, an India-based global botanical ingredients company, introduced Ashwa.30, a next-generation ashwagandha extract designed to deliver enhanced energy, endurance, and stress-relief benefits at a low 30 mg daily dose. Such innovation-driven launches highlight the shift toward clinically backed, standardized botanicals. Collectively, these factors position India as a key growth engine in the Asia-Pacific mood ingredients market.
CHINA MOOD INGREDIENTS MARKET TRENDS
China is emerging as a leading market for mood ingredients in the Asia-Pacific region, driven by high urban stress levels, competitive work environments, and increasing focus on preventive health solutions. Growth is supported by large-scale functional food and beverage production, where mood-support ingredients are being incorporated into ready-to-drink beverages, dairy products, and fortified foods. The country’s advanced processing and formulation capabilities enable bioactives to achieve improved stability, taste, and application versatility, meeting consumer expectations for convenience and efficacy.
For instance, in November 2025, Natural Field Co., Ltd, a China-based high-tech nutrition ingredient company, launched its NF Ashwa, a Ashwagandha Extract series, featuring water-soluble and debittered extracts designed for enhanced taste and adaptability across beverages, functional foods, and dietary supplements. Such innovations demonstrate China’s focus on scalable, consumer-friendly mood-support solutions, reinforcing its position as a major growth driver in the Asia-Pacific mood ingredients market.
GROWING EMPHASIS ON COGNITIVE HEALTH ACCELERATES MOOD INGREDIENTS ADOPTION IN NORTH AMERICA
North America is the dominating region in the global mood ingredients market, holding an estimated 38.10% share in 2025, driven by strong consumer focus on mental well-being and preventive health. Widespread adoption of dietary supplements, functional foods, and beverages, along with a well-established nutraceutical industry, is fueling demand for botanical extracts, amino acids, vitamins, and probiotics and postbiotics. Advanced research infrastructure and emphasis on clinically validated, science-backed formulations support rapid innovation and premium product development.
For instance, in November 2025, Maypro Industries, a U.S.‑based global nutraceutical ingredient supplier, partnered with ClostraBio to launch CLB101, a next‑generation Anaerostipes caccae probiotic strain capable of directly producing butyrate to support gut integrity and microbiome balance, marking a significant step in bringing advanced gut‑brain axis‑related ingredients into the North American supplement market.
U.S. MOOD INGREDIENTS MARKET INSIGHTS
The U.S. remains the largest market for mood ingredients globally, driven by high consumer awareness of mental wellness, preventive health, and functional nutrition. Consumers increasingly demand science-backed, convenient formats such as gummies, beverages, and fortified foods. Strong nutraceutical infrastructure and research capabilities support rapid innovation in botanical extracts, amino acids, probiotics and postbiotics, and mood-supporting botanicals. Clinically validated formulations and premium positioning continue to reinforce market leadership.
For instance, in June 2025, OLLY Vitamins, a U.S.-based wellness brand, launched OLLY Mood + Skin, a science-backed personal care line featuring body washes, scrubs, and serums formulated with mood-enhancing fragrances and clinically supported vitamin complexes to support emotional well-being and skin health. Similarly, in November 2025, Maypro Industries partnered with ClostraBio to launch CLB101, a next-generation probiotic strain supporting gut integrity and the gut–brain axis. Such innovations highlight the focus on consumer-friendly, clinically validated mood solutions, reinforcing its global dominance.
CANADA MOOD INGREDIENTS INDUSTRY GROWTH
Canada is emerging as a strong growth market for mood ingredients, driven by rising interest in cognitive health, natural nootropics, and functional wellness products. Regulatory support for dietary supplements and functional foods, combined with a health-conscious consumer base, is encouraging product development and adoption. Canadian companies are increasingly leveraging biotech and innovative delivery formats to bring new solutions to market. Partnerships and acquisitions are strengthening domestic capabilities while expanding North American reach.
For instance, in August 2025, Doseology Sciences Inc., a Canada-based biotech innovation company, completed the acquisition of the Feed That Brain™ division, expanding its portfolio with a wellness brand focused on cognitive performance and mental health supplements. This move enhances Canada’s contribution to North America’s mood-support ecosystem, demonstrating strategic investment in clinically validated, consumer-ready formulations. The activities reinforce Canada’s growing importance in the regional market.
SUSTAINABILITY ANALYSIS
The global mood ingredients market is increasingly integrating sustainability into ingredient sourcing and production, as companies focus on natural, plant-based, and responsibly sourced compounds to meet consumer demand for environmentally conscious nutrition. Ingredients such as botanical extracts, prebiotics, probiotics, and omega-3s are now being developed with a focus on reducing ecological impact while maintaining functional efficacy. The primary environmental footprint arises from agricultural cultivation, extraction processes, and transportation, where energy, water, and raw material usage contribute to overall carbon emissions.
However, sustainability initiatives are accelerating across the industry. Programs like Nexira’s Carbon‑Neutral Natural Acacia Program use sustainably harvested acacia to produce prebiotic fibers with a minimal carbon footprint, while the Arctic Blue Omega Sustainable Omega‑3 Initiative repurposes by-products from MSC-certified cod oil to reduce environmental impact and provide high-quality omega-3s for brain and mood health. By adopting such eco-friendly sourcing and production strategies, ingredient suppliers are lowering the environmental footprint of mood-support products, while also creating a competitive advantage as consumers increasingly favor clean-label, ethical, and sustainable functional ingredients.
COMPETITIVE LANDSCAPE
Source : DataM Intelligence• The global mood ingredients market is characterized by a competitive landscape that includes both established and regional players.
• Key players include DSM-Firmenich, BASF SE, Archer Daniels Midland Company (ADM), Cargill, Incorporated, Kerry Group plc, Ingredion Incorporated, Tate & Lyle PLC, International Flavors & Fragrances, Inc. (IFF), Ajinomoto Co., Inc., and Lonza Group AG.
KEY DEVELOPMENTS
• In 2025, Givaudan, a Switzerland-based flavor and ingredient manufacturer, launched Zensera, a clinically researched lemon balm extract that supports cognitive performance and stress management at a low 300 mg dose, providing brands with a clean‑label, natural ingredient for incorporation into beverages and nutraceuticals aimed at mood support.
• In 2025, OmniActive Health Technologies, an India-based botanicals and functional ingredient company, expanded the reach of its Sleeproot and Zenroot plant-based extracts for mood, stress, and sleep into key European markets, enabling formulators to include clinically backed botanical solutions in functional foods, beverages, and supplements.
• In 2025, Celsius Holdings, a U.S.-based performance beverage and wellness company, completed the acquisition of Alani Nu, broadening its portfolio with a leading functional beverage and supplement brand and strengthening its position in the mood and wellness segment.
WHY CHOOSE DATAM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
TARGET AUDIENCE 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
Emerging Companies
Table of Contents
180 Pages
- 1. Methodology and Scope
- 1.1. Research Data
- 1.1.1. Secondary Data
- 1.1.2. Primary Data
- 1.1.3. CAGR Analysis
- 1.2. Market Size Estimation Methodology
- 1.2.1. Bottom-Up Approach
- 1.2.2. Top-Down Approach
- 1.3. Market Breakdown & Data Triangulation
- 1.4. Research Assumptions
- 1.5. Limitations
- 2. Definition and Overview
- 2.1. Study Objectives
- 2.2. Market Definition
- 2.3. Market Scope
- 2.4. Stakeholder Analysis
- 2.5. Currency Considered
- 2.6. Study Period
- 3. Executive Summary
- 3.1. Key Takeaways
- 3.2. Top To Bottom Analysis
- 3.3. Market Share Analysis
- 3.4. Data Points from Key Primary Interviews
- 3.5. Data Points from Key Secondary Databases
- 3.6. Market Snapshot
- 3.7. Geographical Snapshot
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Rising Prevalence of Stress and Anxiety Disorders
- 4.1.1.2. Expansion of Personalized Nutrition
- 4.2. Restraints
- 4.2.1. Regulatory Complexity and Market Adoption Challenges
- 4.2.2. Impact Analysis – Drivers and Restraints
- 4.2.3. Opportunity
- 4.2.3.1. Expansion in Functional Foods and Beverages
- 4.2.3.2. Technological Innovation in Delivery Formats
- 4.2.4. Trends
- 4.2.5. Challenges
- 5. Industry Analysis
- 5.1. Porter’s Five Force Analysis
- 5.2. Political Factors
- 5.3. Social Factors
- 5.3.1. Changing Consumer Trends
- 5.3.2. Population Growth
- 5.3.3. Demographic Shifts
- 5.4. Economic Factors
- 5.4.1. Interest Rates
- 5.4.2. Disposable Incomes
- 5.4.3. Inflation
- 5.4.4. GDP
- 5.4.5. Exchange Rates
- 5.4.6. Unemployment Rates
- 5.5. Geopolitical Factors
- 5.6. Supply/Value Chain Analysis
- 5.7. Pricing Analysis
- 5.8. Tariff Analysis
- 5.8.1. Overview Of Relevant Tariffs
- 5.8.2. Trade Policies Influencing the Market
- 5.8.3. Cost Impact Factors
- 5.8.4. Supply Chain Disruptions
- 5.9. Trade Analysis - Export-Import Scenario
- 5.10. Regulatory Analysis
- 5.11. Technology Landscape
- 5.12. Go-To-Market (GTM) Strategy
- 5.13. Innovation & R&D Trends
- 5.14. Sustainability and ESG Analysis
- 5.15. Key Strategic Initiatives
- 5.15.1. Emerging Players and Startups
- 5.15.2. Major Players
- 5.16. DMI Opinion
- 6. By Ingredient Type
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
- 6.1.2. Market Attractiveness Index, By Ingredient Type
- 6.2. Botanical Extracts*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Adaptogens
- 6.2.4. Ashwagandha
- 6.2.5. Rhodiola Rosea
- 6.2.6. Ginseng
- 6.2.7. Others
- 6.3. Proteins and Amino Acids
- 6.3.1. L-Theanine
- 6.3.2. Tryptophan
- 6.3.3. Tyrosine
- 6.3.4. Others
- 6.4. Vitamins and Minerals
- 6.4.1. Vitamin B6
- 6.4.2. Vitamin B12
- 6.4.3. Folate
- 6.4.4. Magnesium
- 6.4.5. Zinc
- 6.4.6. Others
- 6.5. Probiotics and Postbiotics
- 6.5.1. Lactobacillus strains
- 6.5.2. Bifidobacterium strains
- 6.5.3. Others
- 6.6. Omega Fatty Acids
- 6.6.1. Omega-3
- 6.6.2. Omega-6
- 6.7. Others
- 7. By Application
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
- 7.2. Dietary Supplements*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Functional Foods and Beverages
- 7.4. Personal Care and Beauty Products
- 7.5. Pet Nutrition and Supplements
- 7.6. Pharmaceuticals
- 7.7. Others
- 8. By Health Benefit
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
- 8.1.2. Market Attractiveness Index, By Health Benefit
- 8.2. Stress Reduction*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Mood Elevation
- 8.4. Anxiety Relief
- 8.5. Sleep Support
- 8.6. Cognitive Balance and Focus
- 8.7. Hormonal Mood Regulation
- 8.8. Others
- 9. By Source
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.1.2. Market Attractiveness Index, By Source
- 9.2. Plant-Based*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Animal-Based
- 9.4. Synthetic or Bioidentical
- 9.5. Fermented or Biotechnological
- 10. By Distribution Channel
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.1.2. Market Attractiveness Index, By Distribution Channel
- 10.2. B2B Ingredient Suppliers*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. B2C
- 10.3.1. Online Retail
- 10.3.2. Specialty Stores
- 10.3.3. Pharmacies
- 11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.8.1. US
- 11.2.8.2. Canada
- 11.2.8.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.8.1. Germany
- 11.3.8.2. UK
- 11.3.8.3. France
- 11.3.8.4. Russia
- 11.3.8.5. Spain
- 11.3.8.6. Italy
- 11.3.8.7. Norway
- 11.3.8.8. Netherlands
- 11.3.8.9. Sweden
- 11.3.8.10. Denmark
- 11.3.8.11. Belgium
- 11.3.8.12. Switzerland
- 11.3.8.13. Austria
- 11.3.8.14. Poland
- 11.3.8.15. Finland
- 11.3.8.16. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.8.1. Brazil
- 11.4.8.2. Argentina
- 11.4.8.3. Rest of South America
- 11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.5.8.1. China
- 11.5.8.2. India
- 11.5.8.3. Japan
- 11.5.8.4. Australia
- 11.5.8.5. South Korea
- 11.5.8.6. New Zealand
- 11.5.8.7. Indonesia
- 11.5.8.8. Malaysia
- 11.5.8.9. Philippines
- 11.5.8.10. Singapore
- 11.5.8.11. Thailand
- 11.5.8.12. Vietnam
- 11.5.8.13. Rest of Asia-Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.6.8.1. UAE
- 11.6.8.2. Saudi Arabia
- 11.6.8.3. South Africa
- 11.6.8.4. Israel
- 11.6.8.5. Egypt
- 11.6.8.6. Turkey
- 11.6.8.7. Qatar
- 11.6.8.8. Kuwait
- 11.6.8.9. Oman
- 11.6.8.10. Bahrain
- 11.6.8.11. Rest of Middle East and Africa
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Share Analysis – Global
- 12.3. Market Share Analysis – North America
- 12.4. Market Share Analysis - Europe
- 12.5. Market Share Analysis – Asia-Pacific
- 12.6. Mergers and Acquisitions Analysis
- 12.7. Partner Identification Analysis
- 12.8. Investment & Funding Landscape
- 12.9. Strategic Alliances & Innovation Pipeline
- 13. Company Profiles
- 13.1. DSM-Firmenich*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Revenue Analysis
- 13.1.4. Pricing Analysis
- 13.1.5. SWOT Analysis
- 13.1.6. Recent Developments
- 13.1.6.1. Major Deals
- 13.1.6.2. M&A
- 13.1.6.3. Collaboration
- 13.1.6.4. Acquisition
- 13.1.6.5. Joint Ventures
- 13.1.6.6. Innovations
- 13.1.7. Recent News
- 13.1.7.1. Events
- 13.1.7.2. Conferences
- 13.1.7.3. Symposiums
- 13.1.7.4. Webinars
- 13.2. BASF SE
- 13.3. Archer Daniels Midland Company (ADM)
- 13.4. Cargill, Incorporated
- 13.5. Kerry Group plc
- 13.6. Ingredion Incorporated
- 13.7. Tate & Lyle PLC
- 13.8. International Flavors & Fragrances, Inc. (IFF)
- 13.9. Ajinomoto Co., Inc.
- 13.10. Lonza Group AG (LIST NOT EXHAUSTIVE )
- 14. Appendix
- 14.1. About Us and Services
- 14.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
